Inflammation in alcoholic liver disease

Annual Review of Nutrition

Volumn 32, Issue , 2012, Pages 343-368

  Wang, H Joe ^a   Gao, Bin ^a   Zakhari, Samir ^a   Nagy, Laura E ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Complement; Cytokines; Ethanol; Hepatic macrophage; Inflammasome; Liver injury

Indexed keywords

ACETALDEHYDE; ACETIC ACID; ACETYLCYSTEINE; ADIPONECTIN; ANTIOXIDANT; COMPLEMENT; CORTICOSTEROID; FATTY ACID; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PENTOXIFYLLINE; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; S ADENOSYLMETHIONINE; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADDUCTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALCOHOLISM; ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; BONE MARROW CELL; CELL DAMAGE; DRUG TARGETING; EPIGENETICS; HUMAN; HYPOXIA; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFLAMMATION; LIVER CELL; LIVER PROTECTION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIOXIDANTS; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; LIVER DISEASES, ALCOHOLIC;

EID: 84864216017     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-072610-145138     Document Type: Review

References (159)

1. Adachi Y, Bradford BU, GaoW, Bojes HK, Thurman RG.1994. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20:453-60 (Pubitemid 24233374)
2. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. 1995. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218-24
3. Aldred A, Nagy LE. 1999. Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNF-alpha production in rat Kupffer cells. Am. J. Physiol. 276:G98-106
4. Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C. 2010. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J. Neurosci. 30:8285-95
5. Anstee QM, Daly AK, Day CP. 2011. Genetics of alcoholic and nonalcoholic fatty liver disease. Semin. Liver Dis. 31:128-46
6. Arteel GE, Raleigh JA, Bradford BU, Thurman RG. 1996. Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. Am. J. Physiol. 271:G494-500
7. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, et al. 2003. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112:1383-94 (Pubitemid 38057692)
8. Bautista AP. 1997. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Hepatology 25:335-42 (Pubitemid 27069052)
9. Bautista AP. 2002. Neutrophilic infiltration in alcoholic hepatitis. Alcohol 27:17-21 (Pubitemid 34626479)
10. Blanco AM, Perez-Arago A, Fernandez-Lizarbe S, Guerri C. 2008. Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J. Neurochem. 106:625-39
11. Blanco AM, Valles SL, PascualM, Guerri C. 2005. Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J. Immunol. 175:6893-99 (Pubitemid 41599911)
12. Bode C, Kugler V, Bode JC. 1987. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 4:8-14 (Pubitemid 17045538)
13. Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, et al. 2008. A randomized, double-blinded, placebo-controlledmulticenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 135:1953-60
14. Cederbaum AI, Lu Y, WuD. 2009. Role of oxidative stress in alcohol-induced liver injury. Arch. Toxicol. 83:519-48
15. Chen J, Bao H, Sawyer S, Kunos G, Gao B. 1997. Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem. Biophys. Res. Commun. 239:666-69 (Pubitemid 27504158)
16. Chen X, Sebastian BM, Nagy LE. 2007. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am. J. Physiol. Endocrinol. Metab. 292:E621-28 (Pubitemid 46220588)
17. Chen X, Sebastian BM, Tang H, McMullen MM, Axhemi A, et al. 2009. Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 49:1554-62
18. Christoffersen P, Braendstrup O, Juhl E, Poulsen H. 1971. Lipogranulomas in human liver biopsies with fatty change. A morphological, biochemical and clinical investigation. Acta Pathol.Microbiol. Scand. A 79:150-58
19. Cohen JI, Roychowdhury S, McMullenMR, Stavitsky AB, Nagy LE. 2010. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139:664-74.e1
20. Colell A, Garcia-Ruiz C, Miranda M, Ardite E, Mari M, et al. 1998. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115:1541-51 (Pubitemid 28546006)
21. Cook RT, Schlueter AJ, ColemanRA, Tygrett L, Ballas ZK, et al. 2007. Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion-absence of subset-specific glucocorticoidinduced immune cell loss. Alcohol. Clin. Exp. Res. 31:1746-58 (Pubitemid 47390039)
22. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. 2011. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54:133-44
23. Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, et al. 2011. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G433-41
24. Cubero FJ, Nieto N. 2008. Ethanol and arachidonic acid synergize to activateKupffer cells andmodulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. Hepatology 48:2027-39
25. Davis WD Jr, Culpepper WS. 1948. Cirrhosis of the liver associated with alcoholism; report of acute exacerbation with serial liver biopsies. Ann. Intern. Med. 29:942-58
26. Day CP. 2007. Treatment of alcoholic liver disease. Liver Transpl. 13:S69-75 (Pubitemid 350168178)
27. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, et al. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115:56-65 (Pubitemid 40385505)
28. Duryee MJ, Klassen LW, Freeman TL, Willis MS, Tuma DJ, Thiele GM. 2004. Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduct-mediated cytokine/chemokine release by rat sinusoidal liver endothelial and Kupffer cells. Alcohol. Clin. Exp. Res. 28:1931-38 (Pubitemid 39665212)
29. Eigenbrod T, Park JH, Harder J, Iwakura Y, Nunez G. 2008. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J. Immunol. 181:8194-98
30. El-AssalO, Hong F, Kim WH, Radaeva S, Gao B. 2004. IL-6-deficient mice are susceptible to ethanolinduced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol. Immunol. 1:205-11
31. Elphick DA, Dube AK, McFarlane E, Jones J, Gleeson D. 2007. Spectrum of liver histology in presumed decompensated alcoholic liver disease. Am. J. Gastroenterol. 102:780-88 (Pubitemid 46496603)
32. Enomoto N, Ikejima K, Bradford BU, Rivera CA, Kono H, et al. 2000. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J. Gastroenterol. Hepatol. 15(Suppl.):D20-25 (Pubitemid 30190721)
33. EnomotoN, Schemmer P, Ikejima K, Takei Y, SatoN, et al. 2001. Long-term alcohol exposure changes sensitivity of rat Kupffer cells to lipopolysaccharide. Alcohol. Clin. Exp. Res. 25:1360-67 (Pubitemid 32868346)
34. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, et al. 2008. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G1025-34
35. Forsyth CB, Farhadi A, Jakate SM, Tang Y, ShaikhM, Keshavarzian A. 2009. LactobacillusGGtreatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43:163-72
36. Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, et al. 2000. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol. Clin. Exp. Res. 24:48-54S
37. FukuiH. 2005. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcohol. Clin. Exp. Res. 29:172-79S
38. Gao B. 2004. Therapeutic potential of interleukin-6 in preventing obesity-and alcohol-associated fatty liver transplant failure. Alcohol 34:59-65
39. Gao B, Bataller R. 2011. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572-85
40. Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, et al. 2011. Innate immunity in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G516-25
41. Grove J, Daly AK, Bassendine MF, Day CP. 1997. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26:143-46 (Pubitemid 27280318)
42. Guha M, Bai W, Nadler JL, Natarajan R. 2000. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275:17728-39 (Pubitemid 30430822)
43. Hernandez-Gea V, Friedman SL. 2011. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. Mech. Dis. 6:425-56
44. Hill DB, D'SouzaNB, Lee EY, Burikhanov R, Deaciuc IV, de Villiers WJ. 2002. A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol. Clin. Exp. Res. 26:74-82 (Pubitemid 34093514)
45. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, et al. 2002. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21:32-43 (Pubitemid 34076376)
46. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B. 2004. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40:933-41 (Pubitemid 39288127)
47. Horiguchi N, Ishac EJ, Gao B. 2007. Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation. Alcohol 41:271-80 (Pubitemid 47042332)
48. Horiguchi N, Lafdil F, Miller AM, Park O, Wang H, et al. 2010. Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology 51:1724-34
49. Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, et al. 2008. Cell type-dependent proand anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134:1148-58 (Pubitemid 351451970)
50. Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, et al. 2008. The critical role of tolllike receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48:1224-31
51. Iimuro Y, Gallucci RM, LusterMI, Kono H, Thurman RG. 1997. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530-37 (Pubitemid 27520019)
52. Ikeda R, Ishii K, Hoshikawa Y, Azumi J, Arakaki Y, et al. 2011. Reactive oxygen species and NADPH oxidase 4 induced by transforming growth factor beta1 are the therapeutic targets of polyenylphosphatidylcholine in the suppression of human hepatic stellate cell activation. Inflamm. Res. 60:597-604
53. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, et al. 2009. Acetaminopheninduced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119:305-14
54. Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E. 2011. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol. Clin. Exp. Res. 35:1509-18
55. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, et al. 2009. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA 106:20388-93
56. Jaeschke H, Smith CW. 1997. Mechanisms of neutrophil-induced parenchymal cell injury. J. Leukoc. Biol. 61:647-53 (Pubitemid 27276056)
57. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, et al. 2007. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46:823-30 (Pubitemid 47436129)
58. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-84
59. Kendrick SF, O'Boyle G, Mann J, Zeybel M, Palmer J, et al. 2010. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology 51:1988-97
60. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. 1991. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267-76
61. Ki SH, ParkO, Zheng M, Morales-Ibanez O, Kolls JK, et al. 2010. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52:1291-300
62. Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, et al. 2008. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42:675-82
63. Kishore R, Hill JR, McMullen MR, Frenkel J, Nagy LE. 2002. ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G6-15
64. Kishore R, McMullen MR, Nagy LE. 2001. Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 276:41930-37
65. Kono H, Karmarkar D, Iwakura Y, Rock KL. 2010. Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death. J. Immunol. 184:4470-78
66. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, et al. 2000. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest. 106:867-72
67. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, et al. 2010. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring) 18:937-44
68. Lafdil F, Wang H, Park O, ZhangW, Moritoki Y, et al. 2009. Myeloid STAT3 inhibitsTcell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 137:2125-35.e2
69. Lakshminarayanan V, Beno DW, Costa RH, Roebuck KA. 1997. Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factor-alpha in endothelial and epithelial cells. J. Biol. Chem. 272:32910-18 (Pubitemid 28023627)
70. Latvala J, Hietala J, Koivisto H, Jarvi K, Anttila P, Niemela O. 2005. Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease.Am. J. Gastroenterol. 100:1303-10 (Pubitemid 40904353)
71. Lee JY, Sohn KH, Rhee SH, Hwang D. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276:16683-89
72. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, et al. 2009. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49:646-57
73. Lieber CS, Casini A, DeCarli LM, Kim CI, Lowe N, et al. 1990. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11:165-72 (Pubitemid 20101461)
74. Louvet A, Teixeira-Clerc F, Chobert MN, Deveaux V, Pavoine C, et al. 2011. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54:1217-26
75. Lucey MR, Mathurin P, Morgan TR. 2009. Alcoholic hepatitis. N. Engl. J. Med. 360:2758-69
76. MacGregor RR, Gluckman SJ, Senior JR. 1978. Granulocyte function and levels of immunoglobulins and complement in patients admitted for withdrawal from alcohol. J. Infect. Dis. 138:747-55
77. Malhi H, Gores GJ. 2008. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 28:360-69
78. Mallory FB. 1911. Cirrhosis of the liver. Bull. Johns Hopkins Hosp. 22:69-74
79. Mandal P, Park PH, McMullen MR, Pratt BT, Nagy LE. 2010. The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells. Hepatology 51:1420-29
80. Mandal P, Pratt BT, Barnes M, McMullenMR, Nagy LE. 2011. Molecular mechanism for adiponectindependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J. Biol. Chem. 286:13460-69
81. Mandal P, Roychowdhury S, Park PH, Pratt BT, Roger T, Nagy LE. 2010. Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure. J. Immunol. 185:4928-37
82. Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. 2011. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54:2185-97
83. Mathurin P, Mendenhall CL, Carithers RL Jr, RamondMJ, Maddrey WC, et al. 2002. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J. Hepatol. 36:480-87 (Pubitemid 34407335)
84. Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, et al. 2011. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 60:255-60
85. Mato JM, Camara J, Fernandez de Paz J, Caballeria L, Coll S, et al. 1999. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J. Hepatol. 30:1081-89 (Pubitemid 29278753)
86. Mavrelis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK. 1983. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 3:226-31 (Pubitemid 13165374)
87. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. 1999. Cytokines in alcoholic liver disease. Semin. Liver Dis. 19:205-19
88. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S. 2002. Monocyte activation in alcoholic liver disease. Alcohol 27:53-61 (Pubitemid 34626485)
89. McVicker BL, Tuma PL, Kharbanda KK, Lee SM, Tuma DJ. 2009. Relationship between oxidative stress and hepatic glutathione levels in ethanol-mediated apoptosis of polarized hepatic cells. World J. Gastroenterol. 15:2609-16
90. Miller AM, Wang H, Bertola A, Park O, Horiguchi N, et al. 2011. Inflammation-associated IL-6/STAT3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in IL-10 deficient mice. Hepatology 54:846-56
91. Miller AM, Wang H, Park O, Horiguchi N, Lafdil F, et al. 2010. Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury. Alcohol. Clin. Exp. Res. 34:719-25
92. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, et al. 2010. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139:323-34.e7
93. Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, et al. 2007. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46:831-40 (Pubitemid 47436130)
94. Nagy LE. 2003. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp. Biol. Med. (Maywood ) 228:882-90 (Pubitemid 37163241)
95. Nanji AA, FrenchSW.1989. Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci. 44:223-27 (Pubitemid 19028929)
96. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Dannenberg AJ. 2001. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J. Pharmacol. Exp. Ther. 299:638-44 (Pubitemid 32979677)
97. Nanji AA, Khettry U, Sadrzadeh SM. 1994. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 205:243-47 (Pubitemid 24108319)
98. Nanji AA, Tsukamoto H, French SW. 1989. Relationship between fatty liver and subsequent development of necrosis, inflammation and fibrosis in experimental alcoholic liver disease. Exp. Mol. Pathol. 51:141-48 (Pubitemid 20001028)
99. Nath B, Levin I, Csak T, Petrasek J, Mueller C, et al. 2011. Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53:1526-37
100. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. 2001. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J. Hepatol. 34:248-53 (Pubitemid 32176446)
101. Nizet V, Johnson RS. 2009. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9:609-17
102. Nolan JP. 2010. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 52:1829-35
103. O'Shea RS, Dasarathy S, McCullough AJ. 2010. Alcoholic liver disease. Hepatology 51:307-28
104. Oak S, Mandrekar P, Catalano D, Kodys K, Szabo G. 2006. TLR2-and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes. J. Immunol. 176:7628-35 (Pubitemid 43849063)
105. OuchiN, Kihara S, Arita Y, OkamotoY, Maeda K, et al. 2000. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296-301
106. Paik YH, IwaisakoK, Seki E, Inokuchi S, Schnabl B, et al. 2011. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologuesNOX1 and NOX2/gp91(phox)mediate hepatic fibrosis inmice. Hepatology 53:1730-41
107. Park O, Wang H, Weng H, Feigenbaum L, Li H, et al. 2011. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54:252-61
108. Pastorino JG, Hoek JB. 2000. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 31:1141-52 (Pubitemid 30233240)
109. Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, Kim WR. 2010. Alcoholic liver diseaserelated mortality in the United States: 1980-2003. Am. J. Gastroenterol.105:1782-87
110. Petrasek J, Dolganiuc A, Csak T, Nath B, Hritz I, et al. 2011. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 53:649-60
111. PopperH, Thung SN, GerberMA. 1981. Pathology of alcoholic liver diseases. Semin. Liver Dis. 1:203-16
112. Pritchard MT, Nagy LE. 2005. Ethanol-induced liver injury: potential roles for egr-1. Alcohol. Clin. Exp. Res. 29:146-50S
113. Pritchard MT, McMullenMR, Stavitsky AB, Cohen JI, Lin F, et al. 2007. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132:1117-26 (Pubitemid 46440876)
114. Quan Y, Du J, Wang X. 2007. High glucose stimulates GRO secretion from rat microglia via ROS, PKC, and NF-kappaB pathways. J. Neurosci. Res. 85:3150-59 (Pubitemid 350057371)
115. Quan Y, Jiang CT, Xue B, Zhu SG, Wang X. 2011. High glucose stimulates TNFalpha and MCP-1 expression in rat microglia via ROS and NF-kappaB pathways. Acta Pharmacol. Sin. 32:188-93
116. Ramaiah S, Rivera C, Arteel G. 2004. Early-phase alcoholic liver disease: an update on animal models, pathology, and pathogenesis. Int. J. Toxicol. 23:217-31 (Pubitemid 39346621)
117. Ramaiah SK, Jaeschke H. 2007. Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol. Mech. Methods 17:431-40 (Pubitemid 47360087)
118. Rao R. 2009. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50:638-44
119. Rolla R, Vay D, Mottaran E, Parodi M, Traverso N, et al. 2000. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31:878-84 (Pubitemid 30169934)
120. Ronis MJ, Hakkak R, Korourian S, Albano E, Yoon S, et al. 2004. Alcoholic liver disease in rats fed ethanol as part of oral or intragastric low-carbohydrate liquid diets. Exp. Biol. Med. (Maywood ) 229:351-60 (Pubitemid 38372900)
121. Ronis MJ, Korourian S, Zipperman M, Hakkak R, Badger TM. 2004. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. J. Nutr. 134:904-12 (Pubitemid 38456262)
122. Roychowdhury S, McMullen MR, Pritchard MT, Hise AG, van Rooijen N, et al. 2009. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology 49:1326-34
123. Rusyn I, Bradham CA, Cohn L, Schoonhoven R, Swenberg JA, et al. 1999. Corn oil rapidly activates nuclear factor-kappaB in hepatic Kupffer cells by oxidant-dependent mechanisms. Carcinogenesis 20:2095-100 (Pubitemid 29535310)
124. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. 2007. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13:1324-32 (Pubitemid 350073596)
125. Shanmugam N, Reddy MA, Guha M, Natarajan R. 2003. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52:1256-64 (Pubitemid 36523365)
126. Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, et al. 2009. Role of SIRT1 in regulation of LPS-or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G1047-53
127. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, et al. 1993. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 18:41-46 (Pubitemid 23193615)
128. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116:3015-25 (Pubitemid 44684486)
129. Stadlbauer V, Mookerjee RP, Hodges S, Wright GA, Davies NA, Jalan R. 2008. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J. Hepatol. 48:945-51
130. Stadlbauer V, MookerjeeRP, Wright GA, Davies NA, Jurgens G, et al. 2009. Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G15-22
131. Starkel P, De Saeger C, Leclercq I, Strain A, Horsmans Y. 2005. Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis. J. Hepatol. 43:687-95 (Pubitemid 41253237)
132. Stewart S, PrinceM, BassendineM, Hudson M, James O, et al. 2007. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J. Hepatol. 47:277-83 (Pubitemid 47021256)
133. Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, et al. 2003. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 125:202-15 (Pubitemid 36799120)
134. Tabata T, Tani T, Endo Y, Hanasawa K. 2002. Bacterial translocation and peptidoglycan translocation by acute ethanol administration. J. Gastroenterol. 37:726-31 (Pubitemid 35244114)
135. Tan HH, Virmani S, Martin P. 2009. Controversies in the management of alcoholic liver disease. Mt. Sinai J. Med. 76:484-98
136. Thakur V, Pritchard MT, McMullen MR, Nagy LE. 2006. Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G998-1007
137. Thakur V, PritchardMT, McMullenMR, Wang Q, Nagy LE. 2006. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J. Leukoc. Biol. 79:1348-56 (Pubitemid 44835570)
138. Thiele GM, Duryee MJ, Willis MS, Tuma DJ, Radio SJ, et al. 2010. Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol. Clin. Exp. Res. 34:2126-36
139. Thurman RG, Bradford BU, Iimuro Y, Frankenberg MV, Knecht KT, et al. 1999. Mechanisms of alcohol-induced hepatotoxicity: studies in rats. Front. Biosci. 4:e42-46
140. TsukamotoH, French SW, Benson N, DelgadoG, Rao GA, et al. 1985. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 5:224-32 (Pubitemid 15115999)
141. Tsukamoto H, Gaal K, French SW. 1990. Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report. Hepatology 12:599-608 (Pubitemid 20382029)
142. Tuma DJ, Thiele GM, Xu D, Klassen LW, Sorrell MF. 1996. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 23:872-80 (Pubitemid 26112004)
143. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. 2001. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34:101-8 (Pubitemid 32591488)
144. Viitala K, Israel Y, Blake JE, Niemela O. 1997. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption. Hepatology 25:1418-24 (Pubitemid 27250763)
145. Wang H, Lafdil F, Kong X, Gao B. 2011. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int. J. Biol. Sci. 7:536-50
146. Wang HJ, Zakhari S, Jung MK. 2010. Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development. World J. Gastroenterol. 16:1304-13
147. Wen H, Gris D, Lei Y, Jha S, Zhang L, et al. 2011. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12:408-15
148. Xing WW, Zou MJ, Liu S, Xu T, Wang JX, Xu DG. 2011. Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice. Biosci. Biotechnol. Biochem. 75:1290-94
149. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. 2003. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112:91-100 (Pubitemid 38056380)
150. Xu J, Lai KK, Verlinsky A, Lugea A, French SW, et al. 2011. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J. Hepatol. 55:673-82
151. Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, et al. 2011. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53:96-105
152. Yin M, Bradford BU, Wheeler MD, Uesugi T, Froh M, et al. 2001. Reduced early alcohol-induced liver injury in CD14-deficient mice. J. Immunol. 166:4737-42 (Pubitemid 32233762)
153. YinM, Wheeler MD, KonoH, Bradford BU, Gallucci RM, et al. 1999. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117:942-52 (Pubitemid 29468238)
154. You M. 2011. Adiponectin reverses impairment of Sirt1-TNFa axis by LPS or acetate through stimulating AMPK signaling in cultured rat Kupffer cells. Alcohol. Clin. Exp. Res. 35(Suppl. 1):302A
155. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. 2005. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42:568-77 (Pubitemid 41233649)
156. Zakhari S. 2006. Overview: How is alcohol metabolized by the body? Alcohol. Res. Health 29:245-54
157. Zhang X, Tachibana S, Wang H, Hisada M, Williams GM, et al. 2010. Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology 52:2137-47
158. Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, et al. 2008. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J. Immunol. 181:3049-56
159. Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ. 2003. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am. J. Pathol. 163:1137-46 (Pubitemid 37040149)